Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial : Clinical Journal of the American Society of Nephrology

Journal Logo

Original Article: Cystic Kidney Disease

Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease

Randomized Controlled Trial

Mekahli, Djalila1,2; Guay-Woodford, Lisa M.3; Cadnapaphornchai, Melissa A.4; Greenbaum, Larry A.5; Litwin, Mieczyslaw6; Seeman, Tomas7,8; Dandurand, Ann9,10; Shi, Lily11; Sikes, Kimberly11; Shoaf, Susan E.12; Schaefer, Franz13

Author Information
Clinical Journal of the American Society of Nephrology 18(1):p 36-46, January 2023. | DOI: 10.2215/CJN.0000000000000022

Abstract

Copyright © 2023 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid